PLUS1
92.88
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Agilent Technologies | A | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Previous Close | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 2.19 | 2.41% | 92.88 | 91.08 | 93.06 | 91.74 | 90.69 | 20:00:00 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 21,577 | 1,897,108 | $ 92.35 | $ 175,204,770 | 1,608,949 | 61.63 - 93.06 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 251,634 | $ 92.88 | USD |
Agilent Technologies Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 28.68B | 308.78M | 307.66M | $ 5.16B | $ 673.26M | 3.37 | 41.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 4.39M | $ 0.66 | 0.71% | - | - |
Agilent Technologies News
| Date | Time | Source | News Article |
|---|---|---|---|
| 7/01/2020 | 12:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 6/08/2020 | 14:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 6/04/2020 | 16:07 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 6/02/2020 | 16:34 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 6/02/2020 | 16:30 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) |
| 6/01/2020 | 16:30 | Business Wire | Agilent Technologies Announces Pricing of $500 Million of.. |
| 6/01/2020 | 16:22 | Edgar (US Regulatory) | Free Writing Prospectus - Filing Under Securities Act Rules.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical A Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 89.52 | 93.06 | 88.07 | 89.77 | 1,228,464 | 3.36 | 3.75% |
| 1 Month | 87.85 | 93.06 | 84.80 | 88.36 | 1,400,685 | 5.03 | 5.73% |
| 3 Months | 74.75 | 93.06 | 73.42 | 84.16 | 1,881,713 | 18.13 | 24.25% |
| 6 Months | 87.63 | 93.06 | 61.63 | 79.58 | 2,230,274 | 5.25 | 5.99% |
| 1 Year | 71.02 | 93.06 | 61.63 | 77.55 | 2,134,848 | 21.86 | 30.78% |
| 3 Years | 61.60 | 93.06 | 58.22 | 71.72 | 2,060,301 | 31.28 | 50.78% |
| 5 Years | 40.42 | 93.06 | 33.115 | 60.97 | 2,034,851 | 52.46 | 129.79% |
Agilent Technologies Description
| Agilent Technologies Inc has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2019 sales), cross lab (36% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (31%) and China (20%) representing the largest country concentrations. |
